Literature DB >> 2837844

Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation.

S T Roodman1, L W Miller, C C Tsai.   

Abstract

Two-color flow cytometry was used to measure lymphocyte activation antigens, IL-2 receptor (IL-2R), and HLA-DR, on T helper/inducer and cytotoxic/suppressor subsets in the peripheral blood of cardiac transplant patients. Data including 213 cardiac biopsies to determine rejection were obtained on 24 consecutive recipients receiving cyclosporine and prednisone, who survived greater than 5 weeks. The results showed a correlation between the presence of CD4(T4)-IL-2R and rejections or infection occurring within the first 5 weeks posttransplantation. Sensitivity was 79% (73% for rejection only) specificity 97%, P less than .001 by Fisher's exact test. The number of T4-IL-2R cells peaked at 213 cells/microliter with a mean lead time of approximately 3 days prior to positive biopsy (n = 8). After 5 weeks posttransplantation, the sensitivity decreased to 35% (25% rejection only). This decrease may be due to the lack of samples immediately prior to biopsy in patients after 5 weeks posttransplantation. CD8(T8)-IL-2R, T8-DR, T4-DR levels did not correlate with rejections. The results suggest that T4-IL-2R cells that escape cyclosporine inhibition are highly correlated with rejection and enumeration may contribute to increased utility of immune monitoring in these patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837844     DOI: 10.1097/00007890-198806000-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation.

Authors:  L M Vaessen; C R Daane; A P Maat; A H Balk; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506.

Authors:  R Keenan; C Kaufman; A Zeevi; S Yousem; T Zerbe; J Armitage; R Kormos; R Duquesnoy; B Griffith; T Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  A comparison of myocardial perfusion and rejection in cardiac transplant patients.

Authors:  Andrew L Rivard; Cory M Swingen; Donnevan Blake; Andrea S Huang; Pooja Kanth; Grete F Thomsen; Erin J Cordova; Leslie W Miller; Richard W Bianco; Norbert Wilke
Journal:  Int J Cardiovasc Imaging       Date:  2007-01-06       Impact factor: 2.357

5.  Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood.

Authors:  L M Vaessen; C C Baan; A J Ouwehand; N H Jutte; A H Balk; B Mochtar; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection.

Authors:  S Ibrahim; D V Dawson; P Van Trigt; F Sanfilippo
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

7.  Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection.

Authors:  K Hisatomi; T Isomura; E Tayama; K Tamehiro; M Ohashi; T Sato; K Kosuga; K Ohishi; Y Imai; K Itoh
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.

Authors:  Tatsuya Takagi; Hirohisa Katagiri; Yongji Kim; Yoshiyuki Suehara; Daisuke Kubota; Keisuke Akaike; Midori Ishii; Kenta Mukaihara; Taketo Okubo; Hideki Murata; Mitsuru Takahashi; Kazuo Kaneko; Tsuyoshi Saito
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

9.  Is cytoimmunological monitoring a safe follow-up method for heart transplantation patients?

Authors:  Faruk Cingoz; Celalettin Gunay; Bilgehan Savas Oz; Mehmet Arslan
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.